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THE BACHELOR’S DEGREE – ENTERING 
THE SCIENCES
Growing up, I always wanted to become a medical 
doctor. Like many young students pursuing medicine, 
I entered my undergraduate degree in the biological 
sciences. The science courses were a struggle for 
me to get through and I found myself even more 
interested in my option courses such as psychology 
or even economics. Nevertheless, I finished my 
biological sciences degree. I did apply to medicine but 
did not get in, so I decided to get a master’s degree 
in order to improve my curriculum vitae in hopes of 
eventually getting into medicine. 
THE MASTER’S DEGREE – ENTERING THE 
SCIENCES
When deciding which research area to pursue for my 
master’s degree, I gravitated toward bone and joint 
research based on my involvement in playing sports 
growing up. I met with several different scientists at 
the Bone and Joint Institute (formerly called the Joint 
Injury and Arthritis Research Group) at the University 
of Calgary, and chose to work in the laboratory of Dr. 
David A. Hart. The first task I was given by the principle 
investigator was to choose a particular project to work 
on. I was given several different scientific papers to 
read, which turned out to be a daunting task. Despite 
having a strong science background, I struggled with 
those papers, getting lost in the scientific jargon. 
Nevertheless, based on what I could glean from those 
papers, the area of bone cell mechanotransduction 
seemed interesting to me. Mechanotransduction is 
aimed at understanding how cells sense, transduce, 
and respond to mechanical loading. It is the process 
that can explain why weightlifters have increased 
bone mass whereas astronauts have decreased 
bone mass. 
My mechanotransduction research focused 
specifically on how the bone forming cells, 
osteoblasts, respond to different types of mechanical 
loading. I would apply different loading modalities onto 
cells, such as stretching or compressing cells using 
special instrumentation. From my studies we found 
that osteoblasts not only responded to mechanical 
loading by regulating the expression of genes, but 
they also responded by physically modifying their 
environment. In other words, osteoblasts, which are in 
a collagen matrix, are able to reorganize collagen by 
pulling on it. This pulling force was established by the 
cytoskeleton, which is the structural framework of the 
cell. Two major components of the cytoskeleton are 
actin and tubulin. Actin and tubulin are similar to the 
molecular cables and struts of a bridge – they provide 
cellular architecture. Without proper organization of 
actin, the pulling force exerted by the cells on the 
collagen matrix is diminished, reducing the potential 
for matrix remodelling.1, 2 Insufficient remodelling 
forms the basis of several bone pathologies such as 
non-union healing of bone and osteoporosis. 
My master’s degree allowed me to perform real 
research through which I was actually able to 
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Figure 1: Cell mediated contraction of collagen gels. Top 
view of gels within a culture dish. Cells are placed within 
a collagen solution, which gels when placed in a 37oC 
incubator. After 48 hours, the gels are detached from the 
sides of the culture dish. The cells that are within the gels 
contract the collagen gels as shown in Panel A. However, 
this contraction is dependent on actin as treatment of 
cells in collagen with actin inhibitor (latrunculin B) prior to 
detachment prevents collagen gel contraction as shown in 
Panel B. Dashed lines represent perimeter of gels.
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contribute to the world’s wealth of 
scientific knowledge. I was even 
given the opportunity to present at 
scientific conferences and publish 
my findings scientific journals. 
These experiences left me thirsty 
for knowledge and hungry for 
more research. 
THE PH.D. – NO LOOKING 
BACK
After completing my master’s 
degree, I wanted to further 
advance my research expertise by 
embarking on a Ph.D. I discussed 
this interest with my master’s 
degree supervisor. He urged me 
to pursue research away from the 
University of Calgary as this was 
where I did my master’s degree 
and a change in the research 
environment would be an asset 
in terms of my career. Through 
my exploration of other areas of 
research, I became intrigued by 
bioengineering, which involves 
developing replacement body 
parts using a patient’s own cells. 
This interest inspired me to move 
to Toronto to work with Dr. Rita 
Kandel, a pioneer in articular 
cartilage bioengineering research. 
Articular cartilage is the white 
glistening tissue that resides on 
the top ends of bone joints and 
provides a nearly frictionless 
surface for joint movement. 
Unlike other tissues, such as 
bone or skin, articular cartilage is 
incapable of self-repair. Damage 
to articular cartilage results in 
progressive degradation and, as 
a consequence, joint replacement 
is often necessary. Replacements 
consist of replacing cartilage 
with metal/plastic/ceramics, 
which have a limited lifespan 
and eventually require revision. 
Thus, these replacements 
are not optimal and patients 
would certainly benefit from 
bioengineered articular cartilage.  
Articular cartilage has a unique 
composition. Two essential 
molecules present in cartilage 
matrix are proteoglycans and 
collagens. The cartilage cells, 
which are called chondrocytes, 
mainly produce the proteoglycan 
aggrecan and type II collagen; 
these molecules are essential 
for cartilage to withstand 
mechanical loads. A major aim 
in bioengineering cartilage is to 
produce tissue that approximates 
articular cartilage with high 
expression of these molecules. 
In 1995, a breakthrough 
study showed that culturing 
chondrocytes at high density in 
three-dimensional culture could 
result in the generation of articular 
cartilage tissue.3 Importantly, 
this study demonstrated that 
bioengineering of articular 
cartilage was possible. 
At this point, a lingering issue in the 
field of bioengineering was how 
to scale up to replace an entire 
human joint. To accomplish this, 
a large number of chondrocytes 
capable of depositing matrix rich 
in type II collagen and aggrecan 
are needed. Unfortunately, 
chondrocytes are limited in number. 
Chondrocytes can be placed in 
culture dishes to proliferate and 
increase the number of cells. 
However, expanded cells undergo 
a process of dedifferentiation, 
which results in the failure of 
cells to express cartilage matrix 
and they express high levels of 
type I collagen instead. This is 
indicative of fibrocartilage, which 
is inferior to articular cartilage 
and is incapable of meeting the 
mechanical demands of the joint. 
For my research, I was tasked 
with finding out what regulates 
this dedifferentiation process 
in chondrocytes. The first thing 
I noticed when I looked in the 
microscope was the stark contrast 
in the sizes and shapes of the 
cells. Initially chondrocytes were 
small and round, but after a few 
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Figure 3: Control of type I 
collagen gene expression 
through the actin polymerization 
in passaged chondrocytes. 
Passaged chondrocytes contain 
a high proportion of F-actin. Actin 
depolymerization through latrunculin 
B treatment increases G-actin 
monomer concentration. G-actin 
attracts MRTF and pulls MRTF from 
the promoter CArG promoter regions 
of type I collagen and brings it into the 
cytoplasm of the cells. This supresses 
gene expression of type I collagen.
Figure 2: Confocal microscopy 
images of freshly isolated primary 
chondrocyte and culture expanded 
passaged cells stained for F-actin 
using FITC-phalloidin. Primary 
chondrocytes are smaller and have a 
cortical distribution of actin whereas 
passaged chondrocytes have actin 
organized into stress fibers throughout 
the cytoplasm. Scale bar = 10um.
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days chondrocytes became 
larger and began to spread out. 
From my previous studies, I knew 
that the cellular cytoskeleton 
could regulate this change in cell 
size and shape. Upon further 
investigation of the literature, I 
discovered that it was initially 
demonstrated over several 
decades ago that the actin 
cytoskeleton could regulate the 
production of cartilage matrix. 
But the molecular mechanisms 
by which the cell did this were still 
was unclear. So it became my 
objective to find the connection 
between the actin cytoskeleton 
and matrix gene expression. 
Work being performed in other 
types of cells had shown that 
a transcription factor called 
myocardin-related transcription 
factor-a (MRTF) could regulate 
the expression of type I collagen. 
4 MRTF, when inside the nucleus 
of cells, binds to the promoter 
regions of genes and drives the 
expression of certain genes such 
as type I collagen. MRTF can also 
bind actin. Actin could exist as 
monomeric, globular (G-) actin, 
which can polymerize to form 
filamentous (F-) actin and MRTFa 
has a high affinity to G-actin. 
When F-actin is depolymerized 
into G-actin, MRTF binds to 
the G-actin, is exported from 
the nucleus to the cytoplasm, 
and gene expression could be 
decreased. 
Based on these findings in 
other cell types, the hypothesis 
for my project formed: Actin 
polymerization regulates type 
I collagen gene expression in 
passaged chondrocytes through 
MRTF.  To test this hypothesis I 
first measured G-/ F-actin and 
MRTF localization in primary 
and passaged chondrocytes. 
In support of my hypothesis, 
I found that there was more 
G-actin (less F-actin) in primary 
chondrocytes as compared to 
passaged chondrocytes. 5  Next 
I examined the effect of actin 
depolymerization on passaged 
cells in increasing the proportion 
of G-actin. I treated passaged 
chondrocytes with an actin 
depolymerization drug and found 
that not only did this increase 
the proportion of G-actin but it 
also resulted in MRTF export 
to the cytoplasm and reduced 
type I collagen expression. The 
last piece of support for my 
hypothesis was the finding that 
inhibiting MRTF decreased type 
I collagen gene expression. 
Thus, actin regulated type I 
collagen through MRTF. This 
research indicated that MRTF 
regulation  should be considered 
for improving bioengineering of 
articular cartilage. 
I completed my project, defended 
my thesis, published my work 
5-7 and graduated with my Ph.D. 
However, I still have that hunger 
for more research. The next step 
for me is to complete a post-
doctoral research fellowship to 
gain more scientific expertise, 
which is often a required 
step before starting up as an 
independent researcher. I have 
decided to gain further expertise 
in actin research. For this 
pursuit, I will be heading to The 
Scripps Research Institute in San 
Diego, California to a renowned 
actin research laboratory. 
Although I will not be working in 
musculoskeletal research there (I 
will be conducting eye research), 
I would like to one day bridge the 
expertise I gain and apply it in 
musculoskeletal research. I hope 
to eventually return to Canada to 
start my own research lab. 
MY ADVICE FOR STUDENTS
Pursue what interests you
 There is a world of opportunity, so 
do the things that interest you. For 
me it was bone and joint research. 
Look at what research is currently 
being done at institutions in your 
area. Contact researchers at the 
labs that interest you and speak 
with them about potential projects. 
When you go to speak with 
them, be prepared; for example, 
demonstrate your interest in 
their lab by reading some of their 
published research papers. Also, 
make sure you jive with your 
potential supervisor. You can get 
a sense of their personality by 
speaking with them and other 
people in their lab. 
Start early
 I entered the world of research 
relatively late. Many labs accept 
undergraduate students for 
small research projects during 
the summer or for course credit 
during the school year. Some 
even accept high school students. 
So look for these opportunities. 
If you find a laboratory you are 
interested in, it does not hurt to 
contact them to see if there is 
opportunity for you to do work 
there.    
Read, read, read
Although it is very daunting at first 
to read a scientific paper, mainly 
because of the jargon, you will 
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eventually understand and even 
begin to use this jargon. It will be a 
new language to you and will take 
time to learn, so keep at it. Know 
what research has been done in 
your field, and find studies that are 
comparable to your own research, 
so that you do not get stuck trying 
to reinvent the wheel. In addition, 
read papers from outside of your 
field. Other fields of expertise 
can give inspiration for your own 
work. For me, the research being 
performed in vascular research 
gave me insight to my cartilage 
project.         
Consult with others
Others have tackled the same or 
similar problems that you face, so 
speak with them. When you start 
in the lab you will have to learn 
methodology and how to perform 
certain experiments. Often other 
lab members can provide some 
guidance, so don’t be afraid to 
ask them for help. When they 
do teach, make sure to listen 
and take good notes. Along with 
asking specific questions about 
your research, consult with others 
about the ‘big’ decisions, like the 
decision to do another degree 
or post-doc. Make a point to 
develop good relationships with 
your supervisors. I was lucky to 
develop great relationships with 
both my master’s and doctoral 
supervisors. For instance, my 
master’s supervisor guided me in 
choosing my doctoral supervisor. 
Subsequently both my master’s 
and doctoral supervisor gave 
some advice on which lab to select 
for my post-doctoral research. 
Remember that these people can 
only provide you with advice, but 
ultimately these decisions come 
down to you. Nonetheless, it can 
certainly be helpful to hear their 
opinions. For me, my previous 
supervisors continue to act as 
my mentors and have been 
fundamental to my development 
and success.
Don’t be afraid to try something 
new
During your research you will 
invariably ask questions to which 
no one has the answers. To me, 
the exciting part of research 
is answering those types of 
questions. Along the way you may 
encounter naysayers that want to 
discourage you from attempting 
something new in your research, 
but try to ignore them. Discovering 
and observing something no 
one has observed before has to 
be one of the most exhilarating 
feelings. Enjoy it and never stop 
asking questions. 
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